In news this morning, Arcam AB (tickers ARCM.ST on the NASDAQ OMX in Stockholm and AMAVF as the U.S. ADR) announced an order of 5 of the company’s Q10 3D printers by Lima Corporate, (web site). Based in Italy, Lima Corporate develops, manufactures and markets joint replacement and repair solutions including implants for hips, knees, and shoulders.
Arcam also reported the sale of another Q10 system by an unnamed customer in a second press release this morning.
For Q3 Arcam reported the highest level of organic growth I’m aware of in publicly traded 3D printing stocks, with 125% sales growth, and for the January-September period, Arcam earnings were .32/share vs. .07/share.
Arcam took in 5 system orders in Q3, (up from 4 systems in the prior year period). In the last 3 months sales at Arcam have been fast and furious with announced orders for 11 3D printers from customers in Asia, the U.S., Europe, and China.
Follow me on Twitter: @3DPrintingStock
Subscribe to 3DPrintingStocks.com for free (box in left upper corner of page) to get news, articles, interviews, and actionable information on 3D printing stocks delivered to your inbox.
Disclosure: I am long shares of Arcam.
Disclaimer: Opinions expressed are my own and should not be considered investment advice nor an invitation to buy or sell shares of any company mentioned on this site. Investors should perform their own due diligence and consult with a Registered Investment Advisor prior to making any investment decision. See sidebar for full disclaimer.